We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · October 26, 2019

Botulinum Neurotoxin for Jerky and Tremulous Functional Movement Disorders

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Botulinum Neurotoxin Treatment in Jerky and Tremulous Functional Movement Disorders: A Double-Blind, Randomised Placebo-Controlled Trial With an Open-Label Extension
J. Neurol. Neurosurg. Psychiatr. 2019 Nov 01;90(11)1244-1250, YEM Dreissen, JM Dijk, JM Gelauff, E Zoons, D van Poppelen, MF Contarino, R Zutt, B Post, AG Munts, JD Speelman, DC Cath, RJ de Haan, JH Koelman, MAJ Tijssen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading